Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

NCT05697146 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1019

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

OTHER: ribociclib + ET

Sponsor

Novartis Pharmaceuticals